Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders

American Journal of Pathology

Volumn 149, Issue 6, 1996, Pages 2037-2054

  Inoue, Yoshikazu ^b   King Jr , Talmadge E ^b   Tinkle, Sally S ^b   Dockstader, Karen ^b   Newman, Lee S ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ARTICLE; EXTRACELLULAR MATRIX; FEMALE; FIBRIN FORMATION; HUMAN; IMMUNOPATHOGENESIS; LUNG FIBROSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MAST CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION;

ADULT; AGED; BERYLLIOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; COLLAGEN; ELASTIC TISSUE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PULMONARY FIBROSIS; SARCOIDOSIS;

EID: 0029844941     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Walls AF, Roberts JA, Godfrey RC, Church MK, Holgate ST: Histochemical heterogeneity of human mast cells: disease-related differences in mast cell subsets recovered by bronchoalveolar lavage. Int Arch Allergy Appl Immunol 1990, 92:233-241
2. Hunt LW, Colby TV, Weiler DA, Sur S, Butterfield JH: Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc 1992, 67:941-948
3. Hawkins RA, Claman HN, Clark RA, Steigerwald JC: Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis. Ann Intern Med 1985, 102:182-186
4. Ruoss SJ, Hartmann T, Caughey GH: Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991, 88:493-499
5. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990, 346:274-276
6. Bladding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4, 5, and 6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994, 10:471-480
7. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME: Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989, 170:245-257
8. Gordon JR, Galli SJ: Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FcεRI: role for mast cell-derived transforming growth factor-β and tumor necrosis factor-α. J Exp Med 1994, 180:2027-2037
9. Suzuki N, Horiuchi T, Ohta K, Yamaguchi M, Ueda T, Takizawa H, Hirai K, Shiga J, Ito K, Miyamoto T: Mast cells are essential for the full development of silicainduced pulmonary inflammation: a study with mast cell-deficient mice. Am J Respir Cell Mol Biol 1993, 9:475-483
10. Kleeberger SR, Seiden JE, Levitt RC, Zhang LY: Mast cells modulate acute ozone-induced inflammation of the murine lung. Am Rev Respir Dis 1993, 148:1284-1291
11. Takizawa H, Ohta K, Hirai K, Misaki Y, Horiuchi T, Kobayashi N, Shiga J, Miyamoto T: Mast cells are important in the development of hypersensitivity pneumonitis: a study with mast-cell-deficient mice. J Immunol 1989, 143:1982-1988
12. v mice and mechanism of the suppressive effect of tranilast, an anti-allergic drug inhibiting mediator release from mast cells, on fibrosis. Int Arch Allergy Appl Immunol 1991, 95:195-201
13. Jordana M: Mast cells and fibrosis: who's on first? Am J Respir Cell Mol Biol 1993, 8:7-8
14. Henke C, Marineili W, Jessurun J, Fox J, Harms D, Peterson M, Chiang L, Doran P: Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol 1993, 143:1189-1199
15. Rifkin DB, Moscatelli D: Recent development in the cell biology of basic fibroblast growth factor. J Cell Biol 1989, 109:1-6
16. + T cells. Proc Natl Acad Sci USA 1994, 91:2890-2894
17. Vlodavsky I, Fuks Z, Ishai-Michaeli R, Bashkin P, Levi E, Korner G, Bar-Shavit R, Klagsbrun M: Extracellular matrix resident basic fibroblast growth factor: implication for the control of angiogenesis. J Cell Biochem 1991, 45:167-176
18. Gospodarowicz D: Fibroblast growth factor. Crit Rev Oncogene 1989, 1:1-26
19. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G: Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 1987, 8:95-114
20. Leslie CC, McCormick-Shannon K, Mason RJ: Heparinbinding growth factors stimulate DNA synthesis in rat alveolar type II cells. Am J Respir Cell Mol Biol 1990, 2:99-106
21. Lindner V, Reidy MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991, 88:3739-3743
22. Kennedy SH, Qin H, Lin L, Tan EM: Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. Am J Pathol 1995, 146:764-771
23. Henke C, Fiegel V, Peterson M, Wick M, Knighton D, McCarthy J, Bitterman P Identification and partial characterization of angiogenesis bioactivity in the lower respiratory tract after acute lung injury. J Clin Invest 1991, 88:1386-1395
24. Gonzalez AM, Buscaglia M, Fox R, Isacchi A, Sarmientos P, Farris J, Ong M, Martineau D, Lappi DA Baird A: Basic fibroblast growth factor in Dupuytren s contracture. Am J Pathol 1992, 141:661-671
25. Charlotte F, Win KM, Preaux AM, Mavier P, Dhumeaux D, Zafrani ES, Rosenbaum J: Immunolocalization of heparin binding growth factors (HBGF) type 1 and 2 in rat liver: selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. J Pathol 1993, 169: 471-476
26. Reed JA, Albino AP, McNutt NS: Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995, 72:215-222
27. Qu Z, Liebler JM, Powers MR, Galey T, Ahmadi P, Huang XN, Ansel JC, Butterfield JH, Planck SR, Rosenbaum JT: Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995, 147:564-573
28. Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundström C, Nilsson K, Hellman L: Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 1994, 39:489-498
29. Watters LC, Schwarz MI, Cherniack RM, Waldron JA, Dunn TL, Stanford RE, King TE Jr: Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987, 135:696-704
30. Cherniack RM, Colby TV, Flint A, Thurlbeck WM, Waldron JA Jr, Ackerson L, King TE Jr, BAL Cooperative Group Steering Committee: Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991, 144:892-900
31. Newman LS, Kreiss K, King TE Jr, Seay S, Campbell PA: Pathologic and immunologic alterations in early stages of beryllium disease: Re-examination of disease definition and natural history. Am Rev Respir Dis 1989, 139:1479-1486
32. International Labour Organization: Guidelines for the use of ILO international classification of radiographs of pneumoconioses. Occupational Safety and Health Series, No 22. International Labour Office, Geneva, Switzerland, 1980
33. James DG: Clinical picture of sarcoidosis. Interstitial Lung Disease, ed 2. Edited by M Schwartz, TE King Jr. St. Louis, Mosby Year Book, 1993, pp 159-178
34. Willcox M, Kervitsky A, Watters LC, King TE Jr: Quantification of cells recovered by bronchoalveolar lavage: comparison of cytocentrifuge preparations with the filter method. Am Rev Respir Dis 1988, 138:74-80
35. Movat HZ: Demonstration of all connective tissue elements in a single section. Arch Pathol 1955, 60: 289-295
36. Morris AH, Kanner RE, Crapo RO, Gardner RM: Clinical pulmonary function testing. A Manual of Uniform Laboratory Procedures, ed 2. Salt Lake City, Intermountain Thoracic Society, 1984, pp 154-155
37. Goldman HI, Becklake MR: Respiratory function tests: normal values at medium altitudes and the prediction of normal results. Am Rev Tuberculosis 1959, 79:457
38. Ogilvie CM, Forster RE, Blakemore WS, Morton JW: A standardized breathholding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1956, 36:1-17
39. Crapo RO, Morris AH: Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981, 123:185-189
40. Matsuzaki K, Yoshitake Y, Matsuo Y, Sasaki H, Nishikawa K: Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 1989, 86:9911-9915
41. 2-mast cell secretory granule interaction. Histochem J 1993 25:642-647
42. Hyde DM, King TE Jr, McDermott T, Waldron JA Jr, Colby TV, Thurlbeck WM, Flint A, Ackerson L, Cherniack RM: Idiopathic pulmonary fibrosis: quantitative assessment of lung pathology. Am Rev Respir Dis 1992, 146:1042-1047
43. Hirose N, Lynch DA, Cherniack RM, Doherty DE: Correlation between high resolution computed tomography and tissue morphometry of the lung in bleomycin-induced pulmonary fibrosis in the rabbit. Am Rev Respir Dis 1993, 147:730-738
44. Doherty DE, Downey GP, Schwab B, Elson E, Worthen GS: Lipopolysaccharide-induced monocyte retention in the lung: role of monocyte stiffness, actin assembly, and CD18-dependent adherence. J Immunol 1994, 153:241-255
45. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988, 12:345-355
46. Florkiewicz RZ, Sommer A: Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 1989, 86:3978-3981
47. Fu YM. Spirito P, Yu ZX, Biro S, Sasse J, Lei J, Ferrans VJ, Epstein SE, Casscells W: Acidic fibroblast growth factor in the developing rat embryo. J Cell Biol 1991, 114:1261-1273
48. Pertovaara L, Saksela O, Alitalo K: Enhanced bFGF gene expression in response to transforming growth factor-β stimulation of AKR-2B cells. Growth Factors 1993, 9:81-86
49. Bost TW, Riches DWH, Schumacher B, Carré PC, Khan TZ, Martinez JA, Newman LS: Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for TNF-α and IL-6 but not IL-1β. Am J Respir Cell Mol Biol 1994, 10:506-513
50. Yeh J, Osathanondh R: Expression of messenger ribonucleic acids encoding for basic fibroblast growth factor (FGF) and alternatively spliced FGF receptor in human fetal ovary and uterus. J Clin Endocrinol Metab 1993, 77:1367-1371
51. Daniel WW: Applied Non-parametric Statistics, ed 2. Boston, PWS-Kent Publishing Company, 1990, 240-242
52. Saldiva PH, Delmonte VC, de Carvalho CR, Kairalla RA, Auler JO Jr: Histochemical evaluation of lung collagen content in acute and chronic interstitial diseases. Chest 1989, 95:953-957
53. Newman LS, Bobka C, Schumacher B, Daniloff E, Zhen B, Mroz MM, King TE Jr: Compartmentalized immune response reflects clinical severity of beryllium disease. Am J Respir Grit Care Med 1994, 150:135-142
54. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991, 64:841-848
55. Yamashita Y, Nakagomi K, Takeda T, Hasegawa S, Mitsui Y: Effect of heparin on pulmonary fibroblasts and vascular cells. Thorax 1992, 47:634-639
56. Tazawa S, Hayakawa Y, Ishikawa T, Niiya K, Sakaragawa N: Heparin stimulates the proliferation of bovine aortic endothelial cells probably through activation of endogenous basic fibroblast growth factor. Thromb Res 1993, 72:431-439
57. Schwartz LB, Bradford TR: Regulation of tryptase from human lung mast cellis by heparin. J Biol Chem 1986, 261:7372-7379
58. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I: A heparin-binding angiogenic protein, basic fibroblast growth factor, is stored within basement membrane. Am J Pathol 1988, 130:393-400
59. Pesci A, Bertorelli G, Gabrielli M, Olivieri D: Mast cells in fibrotic lung disorders. Chest 1993, 103:989-996
60. Bjermer L, Engström-Laurent A, Thunell M, Hällgren R: The mast cell and signs of pulmonary fibroblast activation in sarcoidosis. Int Arch Allergy Appl Immunol 1987, 82:298-301
61. Schwartz LB: Heterogeneity of human mast cells. The Mast Cell in Health and Disease. Edited by MA Kaliner, DD Metcalfe. New York, Marcel Dekker, 1993, pp 219-236
62. Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Onda M, Kobrin MS, Korc M: Over-expression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993, 53:5289-5296
63. Stopa EG, Gonzalez AM, Chorsky R, Corona RJ, Alvarez J, Bird ED, Baird A: Basic fibroblast growth factor n Alzheimer's disease. Biochem Biophys Res Commun 1990, 171:690-696
64. Renko M, Quarto N, Morimoto T, Rifkin DB: Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 1990, 144:108-114
65. 2-terminal extension of high molecular weight basic fibroblast growth factor is a nuclear targeting signal. J Cell Physiol 1991, 147:311-318
66. Bugler B, Amalric F, Prats H: Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 1991, 11:573-577
67. Florkiewicz RZ, Shibata F, Barankiewicz T, Baird A, Gonzalez AM, Florkiewicz E, Shah N: Basic fibroblast growth factor gene expression. Ann NY Acad Sci 1991, 638:109-126
68. Mignatti P, Morimoto T, Rifkin DB: Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 1992, 151:81-93
69. Dvorak AM: Ultrastructural analysis of human mast cells and basophils. Chem Immunol 1995, 61:1-33
70. Li QY, Raza-Ahmad A, MacAulay MA, Lalonde LD, Rowden G, Trethewey E, Dean S: The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts. Transplantation 1992, 53:1047-1051
71. Kawanami O, Ferrans VJ, Fulmer JD, Crystal RG: Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest 1979, 40:717-734
72. Lykke AW, Schonell ME, Stewart BW: Atypical mast cell degranulation and focal hydropic degeneration of venular endothelium in diffuse fibrosing alveolitis. Experientia 1979, 35:1492-1493
73. Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I: Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989, 28:1737-1743
74. Henson PM, Johnston RB Jr: Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest 1987, 79:669-674
75. 2-exposed rat lung. Am J Physiol 1995, 268:L455-L464